PharmaBoardroom

Interview: Mykola Gumenyuk – CEO, Yuria-Pharm, Ukraine

Mykola Gumenyuk, CEO of Yuria-Pharm, documents the strategy that has been driving the impressive growth of this ambitious company, how Yuria-Pharm has…

Interview: Andrew von Eschenbach – FDA Commissioner (2006…

Speaking exclusively to PharmaBoardroom at the 2017 BIO Convention in San Diego, former FDA Commissioner Andrew von Eschenbach lifts the lid on the…

Interview: Darodjatun Sanusi – Executive Director, GP…

Darodjatun Sanusi, Executive Director of GP Farmasi (National Association of Local Companies in Indonesia), explains the opportunities and challenges…

Shawn Leung – CEO, SinoMab Bioscience, Hong Kong

Shawn, as I understand, SinoMab today is a clinical stage biopharma company focusing on the development of therapeutic monoclonal antibodies (mAbs)…

Interview: Andy Barnett – General Manager (Hong Kong and…

Andy Barnett, general manager (Hong Kong and Macau) for Roche, discusses the highlights of his past two years managing a local affiliate instead of…

Clinical Research in Mexico: Trials and Tribulations

According to a recent World Health Organization study, countries must allocate at least six percent of their GDP to research and development to be…

Interview: Rufi Susanto – President (Core Market) and…

Rufi Susanto, President (Core Market) and Senior Managing Director IDS Medical Systems (idsMED), highlights the company’s commitment to Indonesia…

Interview: Lawrence Wong – General Manager, Ferring…

Lawrence Wong, general manager of Ferring Pharmaceuticals in Hong Kong, discusses the important role of the Hong Kong affiliate in support of regional…